INCY compared with NBIX: revenue, margins and what each company keeps, and the suppliers and customers both name

INCYIncyte Corp

Mkt capRevenueRevenue

NBIXNeurocrine Biosciences Inc

Mkt capRevenueRevenue

Compare

INCYIncyte Corp

NBIXNeurocrine Biosciences Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only INCY 5

MGNXMacrogenicssupplier

PRLDPrelude Therapeuticssupplier

AGENAgenussupplier

—ARIAD/Takedaunlistedsupplier

1 more · INCY chain ›

Shared 0

No shared counterparties.

Only NBIX 9

ABBVAbbViesupplier

XENEXenon Pharmaceuticalssupplier

KRCKilroy Realtysupplier

MAZEMaze Therapeuticssupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

5 more · NBIX chain ›

INCYIncyte Corp

119.70▲+1.43%· post 119.55

Mkt cap$24.4BRevenue$1.6BQ3 FY26Revenue$5.1BFY25

NBIXNeurocrine Biosciences Inc

164.56▲+3.01%· post 164.56

ClosedNov 6 '26

Mkt cap$16.7BRevenue$1.1BQ3 FY26Revenue$2.9BFY25

Compare

ClosedNov 6 '26

INCYIncyte Corp

NBIXNeurocrine Biosciences Inc

119.70▲+1.43%post 119.55

Price

164.56▲+3.01%post 164.56

$24.4B

Mkt cap

$16.7B

Q3 FY26$1.6B

Revenue

$1.1BQ3 FY26

FY25$5.1B

Revenue

$2.9BFY25

INCY119.70▲+1.43%vsNBIX164.56▲+3.01%ClosedNov 6 '26